Skip to content
Lower risk Medical device recall · FDA · Published December 27, 2023

Abiomed Impella catheters: New warnings to prevent blood flow issues

Abiomed recalls Impella catheters (2.5, 5.0, LD, RP, CP models) due to updated warnings to reduce fiber risk that could cause low blood flow. All affected products have new instructions.

🇺🇸 FDA recall #Z-1074-2024Medical deviceAbiomed ›
Take action

Contact the company

Recalling firmAbiomed, Inc.24 Cherry Hill Dr · Danvers, MA 01923-2575
✎ GovInfoNow plain-language explainer

Abiomed is recalling several Impella catheter models because new warnings are needed to prevent fibers from entering the device, which could lead to reduced blood flow. This is a safety update for medical devices used to support circulation. Read more at govinfonow.com/recall/56464-abiomed-impella-catheters-new-warnings-to-prevent-blood-flow-issues.

Source Summary by GovInfoNow · govinfonow.com/recall/56464-abiomed-impella-catheters-new-warnings-to-prevent-blood-flow-issues · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1074-2024

Cite this page

“Abiomed Impella catheters: New warnings to prevent blood flow issues.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/56464-abiomed-impella-catheters-new-warnings-to-prevent-blood-flow-issues. Based on FDA recall #Z-1074-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1074-2024%22&limit=1).

The FDA announced on Dec. 27, 2023, that Abiomed, Inc. is recalling Impella catheters to add new warnings about fiber draw-in risks. The agency issued recall number Z-1074-2024 for the intravascular micro axial blood pumps.

How to tell if you have it

  • Brand: Abiomed
  • Product: Impella catheters (Intravascular micro axial blood pumps)
  • Product Codes: 005042, 005062, 005082, 004334, 0046-0035, 1000323, 0550-0008, 1000100, 0048-0032, 100080, 0048-0045
  • Additional Product Codes: 4413, 004413, 5040, 005040, 5060, 005060, 5064, 005064, 1000115, 1000211, 1000302, 1000361, 1000402, 0046-0011, 0046-0026, 0046-0037, 0046-0039, 004690-AU, 0048-0002, 0048-0002-BR, 0048-0004, 0048-0014, 0048-0024-JP, 0048-0044, 0048-0047, 005048-JP, 005066-JP, 0550-0002, 0550-0004
  • UDI-DI Codes: 00813502011081, 00813502011180, 00813502011227, 00813502011029, 00813502011869, 00813502012811, 00813502011531, 00813502012828, 00813502011388, 00813502012279, 00813502011876, 813502010947, 4260113630136, 4260113630174, 813502011197, 813502010473, 813502012453, 813502012767, 813502012927, 813502012873, 4260113630273, 813502011821, 813502011937, 813502011951, 4260113630242, 813502011777, 813502011265, 4260113630280, 813502011609, 813502012200, 813502011944, 813502010046, 813502010053, 813502011630, 813502010466
  • Quantity: 92,515 units
  • Distribution: Worldwide (US Nationwide; AU, CA, DE, FR, IN, MX, TW, VI)

The hazard

The recall addresses the possibility of fibers being drawn into the Impella device, which may result in low flow. The FDA stated that new warnings are being added to the Instructions for Use for all affected products to mitigate this risk.

Context

GovInfoNow's records show Abiomed, Inc. has 28 other recalls on record since 2019-09-04. Other recent recalls of similar products include Abiomed Impella Controller: Purge Cassette Recognition Issues (2026-08-12), Abiomed Impella CP Smart Assist Set Recall: Introducer Sheath Leakage Risk (2026-06-11), and Abiomed Impella CP Set Recall: Risk of Blood Clots During Prolonged Use (2026-05-22). Other recent recalls of similar products include Merit Medical ProGuide Dialysis Catheters Recall: Risk of Bleeding and Blockage (2026-02-13), Merit Medical BioFlo DuraMax Catheter Recall: Design Defect May Cause Bleeding (2026-02-13), and Medline ViewFlex Xtra ICE Catheters Recall: Risk of Infection from Reprocessed Catheters (2025-12-22).

How to tell if you have this one

Check for Impella 2.5, 5.0, LD, RP, or CP models with specific product codes listed in the recall notice. All affected products have received an updated Instructions for Use.

  • Brand
    Abiomed
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Review Updated Instructions

    Check the product's Instructions for Use for the latest warnings about fiber risks and blood flow.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide distribution - US Nationwide and the countries of AU, CA, DE, FR, IN, MX, TW, and VI.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 56 days after the firm started it.

1. Firm started the recall: Dec 27, 202312. FDA classified it Class II: Feb 12, 202423. Published in FDA’s Enforcement Report: Feb 21, 2024320232024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Do I need to stop using my Impella catheter?

No, the recall involves updated warnings, not a stop-use order. Continue using the device but follow the new instructions.

Is there a risk of serious injury?

The recall addresses a potential risk of reduced blood flow, but the hazard is managed through updated instructions. Serious injury is not expected with proper use.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1074-2024 (December 27, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1074-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA